← All companies
VKTX annual net income
Viking Therapeutics, Inc.
VKTX - CIK 0001607678
Market cap$3.22 B
Rank#1747
SEC filings627
Viking Therapeutics, Inc. net income by year
Viking Therapeutics, Inc. (VKTX) reported net income of -$359.64M for fiscal year 2025, as filed in its audited annual report with the SEC.
VKTX net income 2014-2025
| Fiscal year | Net Income | Change |
|---|---|---|
| FY 2025 | -$359.64M | -227.1% |
| FY 2024 | -$109.96M | -28.0% |
| FY 2023 | -$85.89M | -24.7% |
| FY 2022 | -$68.87M | -25.2% |
| FY 2021 | -$54.99M | -39.2% |
| FY 2020 | -$39.49M | -53.2% |
| FY 2019 | -$25.78M | -16.8% |
| FY 2018 | -$22.06M | -7.2% |
| FY 2017 |
Net Income of similar companies
Frequently asked questions
How much profit does Viking Therapeutics, Inc. make?
Viking Therapeutics, Inc. (VKTX) reported net income of -$359.64M for fiscal year 2025, as filed in its audited annual report with the SEC.
How has Viking Therapeutics, Inc.'s net income changed over time?
Between fiscal 2014 and fiscal 2025, Viking Therapeutics, Inc.'s net income declined from -$21.88M to -$359.64M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.